Evidence of shared genetic factors in the aetiology of gastrointestinal disorders and endometriosis and clinical implications for disease management

Abstract

In clinical practice, the co-existence of endometriosis and gastrointestinal symptoms is often observed; however, the factors driving this link remain largely unknown. Here, using large-scale multifaceted data including observational, genetic, and pharmaceutical datasets, we report a positive phenotypic and genetic association of endometriosis with peptic ulcer disease (PUD), gastro-oesophageal reflux disease (GORD), a combined GORD/PUD Medicated (GPM) phenotype and irritable bowel syndrome (IBS), but not with inflammatory bowel disease (IBD). Mendelian randomization analysis identified a causal effect of the GPM phenotype on endometriosis and a bidirectional causal association between endometriosis and IBS. Cross-trait meta-analysis and colocalization along with comprehensive functional annotation confirmed two shared genetic loci (FN1, TACSTD2) for endometriosis with IBS and twelve loci (ETAA1, HOXC4, RERG, SEMA3F, SPAG16, HIST1H2BC, RAB5B, CCKBRandPDE4B) with GORD and PUD. Shared genetic loci may contribute to risk of both endometriosis and digestive disorders through the involvement of DNA damage, estrogen regulated cell-proliferation and inflammation, and barrier dysfunction. Analyses of medication usage identified a higher use of drugs for IBS, GORD and PUD in women diagnosed with endometriosis as well as a higher use of hormone therapies in women diagnosed with IBS, GORD and PUD but not for IBD, which strongly supports the co-occurrence of these conditions and highlights the potential for drug repositioning and caution around drug contraindications in clinical practice. Taken together, the combined evidence robustly suggests a shared disease aetiology and provides important clinical implications for diagnostic and treatment decisions for endometriosis and digestive disorders.WHAT IS ALREADY KNOWN ON THIS TOPIC?Both endometriosis and gastrointestinal disorders affect a large proportion of people worldwide and the co-existence of endometriosis and gastrointestinal symptoms (eg, abnormal pain, bloating, constipation) is often observed in clinical practice.The association of these two diseases was supported but also limited to previous observational evidence which highlights a three-fold increase in the prevalence of irritable bowel syndrome (IBS) in women with endometriosis.Observational study is easily subject to measurement error, confounding and reverse causation. Therefore, it is important to assess the association using multidimensional datasets and more accurate approaches, such as the use of genetic data in a mendelian randomisation framework as well as the analysis from a perspective of medication usage.WHAT THIS STUDY ADDSGenetic risk factors for endometriosis and gastrointestinal disorders, two leading causes of discomfort and chronic pelvic pain, are correlated.Mendelian randomisation analyses supported a causal relationship between genetic predisposition to gastrointestinal disorders (gastro-oesophageal reflux disease (GORD) and peptic ulcer diseases (PUD)) and endometriosis risk, and evidence for a bidirectional causal relationship between endometriosis and IBS, which might explain in part the co-occurrence of these diseases.The identification of shared risk loci highlighted biological pathways that may contribute to the pathogenesis of both diseases, including estrogen regulation and inflammation, as well as potential therapeutic drug targets such asCCKBRandPDE4B.The higher use of drugs for IBS, GORD and PUD in women diagnosed with endometriosis as well as the higher use of hormone therapies in women diagnosed with IBS, GORD and PUD, support the co-occurrence of these conditions and shared disease aetiology but also highlights the potential for drug repositioning and caution around drug contraindications.Graphical abstract

Single-cell characterization of menstrual fluid at homeostasis and in endometriosis

“…Finally, genetic polymorphisms in cAMP-specific 3’,5’-cyclic phosphodiesterase 4B ( PDE4B ) were recently proposed to be implicated in the etiology of endometriosis (36).…”

The effect of an elimination diet on the functional state of the gastrointestinal tract and liver of childbearing age women having symptomatic adenomyosis

“…Харчова непереносимість порушує роботу шлунково-кишкового тракту, симптоматика патології з боку якого певною мірою подібна до симптоматики аденоміозу, зокрема, пацієнтки висловлюють скарги на дискомфортні відчуття в нижніх відділах живота, відчуття набряку та збільшення розміру живота (у тому числі після споживання їжі та в передменструальний період), періодичні закрепи, відчуття неповного спорожнення кишечника тощо. Це дає змогу висунути гіпотезу, що різні ендокринні дезраптори впливають на нейроендокринну регуляцію та роботу органів травлення, порушуючи їхнє функціонування з розвитком схожих до симптомного аденоміозу клінічних проявів і ознак, які можуть посилюватися в передменструальний період [10,16]. Так, M. Kanzaki та співавт.…”

Heme metabolism and HO‐1 in the pathogenesis and potential intervention of endometriosis

“…The genetics and the immune system trigger the intrinsic changes in the endometrium 4 . EM presents a genetic correlation (rg) with various diseases associated with inflammation and chronic pain 5,6 . The estimated heritability rate is up to 50% 6 .…”